The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci
Open accessAbstract
We used a collection of 708 prospectively collected autopsied brains to assess the methylation state of the brain's DNA in relation to Alzheimer's disease (AD). We found that the level of methylation at 71 of the 415,848 interrogated CpGs was significantly associated with the burden of AD pathology, including CpGs in the ABCA7 and BIN1 regions, which harbor known AD susceptibility variants. We validated 11 of the differentially methylated regions in an independent set of 117 subjects. Furthermore, we functionally validated these CpG associations and identified the nearby genes whose RNA expression was altered in AD: ANK1, CDH23, DIP2A, RHBDF2, RPL13, SERPINF1 and SERPINF2. Our analyses suggest that these DNA methylation changes may have a role in the onset of AD given that we observed them in presymptomatic subjects and that six of the validated genes connect to a known AD susceptibility gene network.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Alterations of DNA methylation levels have been shown to be involved in many diseases, including AD [19–24].”
From Distinct sex-specific DNA methylation differences in Alzheimer’s disease (2022) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DNA methylation is an important epigenetic modification that regulates gene transcription and is known to be involved in AD”
From Sex-specific DNA methylation differences in Alzheimer’s disease pathology (2021) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with previous studies [18, 19, 86, 87], we observed the majority of these sex-specific differences were hyper-methylated in samples with AD neuropathology, for which methylation levels increased as the AD Braak stage increased”
From Sex-specific DNA methylation differences in Alzheimer’s disease pathology (2021) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“dysregulated DNAm has been observed as an early feature of AD neuropathology in the brain [19]”
From Distinct sex-specific DNA methylation differences in Alzheimer’s disease (2022) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, alterations of DNA methylation levels have also been implicated in multiple neurological disorders including AD [18–22]”
From Sex-specific DNA methylation differences in Alzheimer’s disease pathology (2021) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Notably, none of the 14 CpGs detected in our interaction analysis was identified in previous large-scale DNA methylation studies [18–22]”
From Sex-specific DNA methylation differences in Alzheimer’s disease pathology (2021) · cites this paper as [18]
In the citing paper
“These reference epigenomes, combined with other genomics data, have provided functional and causal insights about several human disease (De Jager et al., 2014; Farh et al., 2015; Yao, Tak, Berman, & Farnham, 2014).”
From Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases (2016) · cites this paper as De Jager et al., 2014
In the citing paper
“The most significant GWAS SNP was also a significant eQTL with the same direction of effect as in CMC for FURIN (rs4702: P = 1 × 10−6), CLCN3 (rs10520163: P = 9 × 10−6), and SNAP91 (rs3798869: P = 3 × 10−4); TSNARE1 (rs4129585: P = 0.057) and CNTN4 (rs17194490: P = 0.07) also had alleles in the same direction of effect as in CMC but did not reach significance.”
From Gene expression elucidates functional impact of polygenic risk for schizophrenia (2016) · cites this paper as [26]
In the citing paper
“and two independent genome-wide studies recently identified a differentially methylated region in the ANK1 gene as associated with the burden of AD pathology [198, 199].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [199]
In the citing paper
“A different study found altered methylation in the BIN1 locus at cg22883290 in relation to neuritic amyloid plaques and a pathologic diagnosis of AD, and this altered methylation pattern was independent of the effect of the rs744373 susceptibility variant [14].”
From BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology (2020) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationMeta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Self-citationChromHMM: automating chromatin-state discovery and characterization
Ernst, J., & Kellis, M. (2012) · Nature Methods · doi:10.1038/nmeth.1906 · Cited by 2,457
Self-citationGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Du, P., Zhang, X., Huang, C.-C., Jafari, N., Kibbe, W. A., Hou, L., & Lin, S. M. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-587 · Cited by 2,136 · cited 2×
“We then performed a refinement step similar to that used in “ iSVA” 52 where for each independent component i ( 1 = i =k ) we created a sub-matrix of the beta values populated only by methylation probes that were significantly associated with component i .”
lumi : a pipeline for processing Illumina microarray
Du, P., Kibbe, W. A., & Lin, S. M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn224 · Cited by 2,028
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · cited 1×
“…in the BIN1 locus (beta=4.44, p=9.00×10 −8 ) and cg02308560 in the ABCA7 locus (beta=3.62, p=2.45×10 −12 ) 19-22 . cg22883290, is located 5 kb from the 5’ end of the BIN1 gene and 92 kb from the index SNP, rs744373, that best captures the genetic association to AD in this region ( Figure 2c ) 19 .”
InfluentialSelf-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 975
Alendar, A., Lambooij, J.-P., Bhaskaran, R., Lancini, C., Song, J., van Vugt, H., Snoek, M., & Berns, A. J. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233394 · Cited by 16
“Notably, a number of deregulated genes in CHD9-depleted K562 cells–such as PBX Homeo-box1 ( PBX1) , Apelin receptor (APLNR) and Bridging Integrator 1 (BIN1) –are implicated in neuronal development and pathology [43].”
Luo, S., Zou, K., Zhu, H., Cheng, Y., Yan, Y., Sheng, J., Huang, H., & Ding, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.748862 · Cited by 15
Prolonged diet-induced obesity modifies DNA methylation and gene expression in the hippocampus
Velden, J. W. V., & Osborne, D. M. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136656 · Cited by 15
Integrated DNA Methylation/RNA Profiling in Middle Temporal Gyrus of Alzheimer’s Disease
Piras, I. S., Brokaw, D. L., Kong, Y., Weisenberger, D. J., Krate, J., Delvaux, E., Mahurkar‐Joshi, S., Blattler, A., Siegmund, K. D., Sue, L. I., et al. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01307-3 · Cited by 15
“Results from De Jager et al. (2014) included 71 CpG sites associated at the genome-wide level (p < 1.20E-07) with the burden of AD pathology in the dorsolateral prefrontal cortex.”
InfluentialDnmt3a1 regulates hippocampus-dependent memory via the downstream target Nrp1
Kupke, J., Klimmt, J., Mudlaff, F., Schwab, M., Lutsik, P., Plass, C., Sticht, C., & Oliveira, A. M. M. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01843-0 · Cited by 19
“Images were acquired with a 40× oil objective on a fl uorescence microscope (Leica Microsystems, Oberkochen, Germany).”
MethodWei, Y., Zhou, Y., Xiao, L., Qin, J., Cheng, H., Cai, H., Chen, X., Zou, Y., Li, Y., Zhang, H., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26942 · Cited by 15
“10,11 DNA methylation also acts as an epigenetic marker sensitive to environmental factors, thus making it an ideal candidate mechanism for revealing how exposure to the environment shapes gene expression and contributes to diseases.”
Alzheimer′s disease: Unique markers for diagnosis & new treatment modalities
Aggarwal, N. T., Shah, R. C., & Bennett, D. A. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.169193 · Cited by 19
Self-citationKlein, H., Schäfer, M. K.-H., Bennett, D. A., Schwender, H. R., & Jager, P. L. D. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007771 · Cited by 17
Self-citationKim, B.-H., Initiative, A. D. N., Choi, Y.-H., Yang, J., Kim, S., Nho, K. T., & Lee, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191175 · Cited by 15
“Moreover, two genes ( CD33 and ASGR2 ), that make up components of carbohydrate binding, were previously reported to be associated with AD [92, 93].”
Considerations for integrative multi‐omic approaches to explore Alzheimer's disease mechanisms
Ma, Y., Klein, H., & Jager, P. L. D. (2020) · Brain Pathology · doi:10.1111/bpa.12878 · Cited by 17
“While some of these associations may reflect shifts in cellular population frequency related to disease that have not been accounted for by available methods, others are robust and reproducible but not driven by genetic variation (6).”
BackgroundYang, X., Shao, X., Gao, L., & Zhang, S. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw013 · Cited by 15
Ma, Y., Jun, G., Chung, J., Zhang, X., Kunkle, B. W., Naj, A. C., White, C. C., Bennett, D. A., Jager, P. L. D., Mayeux, R. P., et al. (2019) · Aging Cell · doi:10.1111/acel.12964 · Cited by 13
“For example, brain DNA methylation levels of CpG sites located in the top‐ranked loci have been asso‐ ciated with clinical and pathological diagnoses of AD in a sample of 740 ROSMAP participants, many of whom are included in the ADGC GWAS dataset (De Jager et al., 2014).”
InfluentialSelf-citationdecorate: differential epigenetic correlation test
Hoffman, G. E., Bendl, J. M., Girdhar, K., & Roussos, P. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa067 · Cited by 15
Epigenome‐wide association studies in Alzheimer’s disease; achievements and challenges
van den Hove, D., Riemens, R. J. M., Koulousakis, P., & Pishva, E. (2020) · Brain Pathology · doi:10.1111/bpa.12880 · Cited by 17
Plasma cell-free DNA methylation marks for episodic memory impairment: a pilot twin study
Konki, M., Lindgrén, N., Kyläniemi, M. K., Venho, R., Laajala, E., Ghimire, B. R., Lahesmaa, R., Kaprio, J. A., Rinne, J. O., & Lund, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-71239-9 · Cited by 15
Circulating cell-free DNA as potential diagnostic tools for amyotrophic lateral sclerosis
Robichaud, P.-P., Arseneault, M., O’Connell, C. M., Ouellette, R. J., & Morin, P. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135813 · Cited by 15
Imm, J. L., Kerrigan, T. L., Jeffries, A. R., & Lunnon, K. (2017) · Epigenomics · doi:10.2217/epi-2017-0076 · Cited by 14
Self-citationRuffini, N., Klingenberg, S., Heese, R., Schweiger, S., & Gerber, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.866886 · Cited by 16
Palma‐Gudiel, H., Yu, L., Huo, Z., Yang, J., Wang, Y., Gu, T., Gao, C., Jager, P. L. D., Jin, P., Bennett, D. A., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12761 · Cited by 14
“Abbreviation: Aβ, amyloid β. aGenomic coordinates according to GRCh38. bGene column provides the closest gene annotated to each CpG site. cFDR-adjusted P-values (i.e., q-value). dArray CpG probes that were not reported at a genome-wide threshold of significance in De Jager et al. 2014.”
Self-citationEffects of lifespan-extending interventions on cognitive healthspan
Čulig, L., Sahbaz, B. D., & Bohr, V. A. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.36 · Cited by 14
Zhang, W., Young, J. I., Gomez, L., Schmidt, M. A., Lukacsovich, D., Varma, A., Chen, X. S., Kunkle, B. W., Martin, E. R., & Wang, L. (2024) · Epigenetics · doi:10.1080/15592294.2024.2333660 · Cited by 15
Decoding molecular mechanisms: brain aging and Alzheimer’s disease
Hayat, M., Syed, R. A., Qaiser, H., Uzair, M., Al-Regaiey, K., Khallaf, R. A., Albassam, L. A. M., Kaleem, I., Wang, X., Wang, R., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01403 · Cited by 14
The Role of Aging in Alzheimer’s Disease
Kerchner, G. A., & Wyss‐Coray, T. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_7 · Cited by 14
Liu, G., Ji, H., Liu, J., Xu, C., Chang, L. Y., Cui, W., Ye, C., Hu, H., Chen, Y., Zhou, X., et al. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.11.018 · Cited by 14
Systematic identification of differential gene network to elucidate Alzheimer's disease
Park, C., Yoon, Y., Oh, M., Yu, S. J., & Ahn, J. (2017) · Expert Systems with Applications · doi:10.1016/j.eswa.2017.05.042 · Cited by 15
Accounting for differential variability in detecting differentially methylated regions
Wang, Y., Teschendorff, A. E., Widschwendter, M., & Wang, S. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx097 · Cited by 14
Smith, A. R., Wheildon, G., & Lunnon, K. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12650 · Cited by 14
Self-citationKim, B., Vasanthakumar, A., Li, Q. S., Nudelman, K. N. H., Risacher, S. L., Davis, J. W., Idler, K. B., Lee, J., Seo, S. W., Waring, J. F., et al. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12354 · Cited by 13
Novel Colitis Immunotherapy Targets Bin1 and Improves Colon Cell Barrier Function
Thomas, S., Mercado, J. M., DuHadaway, J. B., DiGuilio, K., Mullin, J. M., & Prendergast, G. C. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3804-8 · Cited by 14
“While there has been little study of Bin1 in inflammatory bowel disease, increased Bin1 expression has been linked broadly to an increased susceptibility of Alzheimer’s disease [26–28].”
BackgroundEthnicity-specific and overlapping alterations of brain hydroxymethylome in Alzheimer’s disease
Qin, L., Xu, Q., Li, Z., Chen, L., Li, Y., Yang, N., Liu, Z., Guo, J., Shen, L. H., Allen, E. G., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz273 · Cited by 14
“In contrast with previous studies that used methods such as bisulfite pyrosequencing (39,52–56) and Illumina HumanMethylation450 beadset (6,7,9,10,40), the methods we have used are able to distinguish 5hmC from 5mC (37,57).”
González-Mundo, I., Pérez-Vielma, N. M., Gómez‐López, M., Fleury, A., Correa‐Basurto, J., Rosales‐Hernández, M. C., Sixto‐López, Y., Martínez–Godínez, M. D. L. Á., Domínguez‐López, A., & Miliar-García, Á. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110951 · Cited by 14
Xiang, X., Du, Y., Li, Z., Fros, J. J., Wei, J., Liu, K., Li, Z., Shao, D., Li, B., Kortekaas, J., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03266-6 · Cited by 15
Shen, X., Barbu, M. C., Caramaschi, D., Arathimos, R., Czamara, D., David, F. S., Dearman, A., Dilkes, E., Herrera-Rivero, M., Huider, F., et al. (2025) · Nature Mental Health · doi:10.1038/s44220-025-00486-4 · Cited by 19
“Genes mapped from cg01150646 ( MYO1C ), cg10604091 ( DLEU2 ) and cg07063853 ( API5 ) were associated with Alzheimer’s disease in brain-tissue methylation levels 23–25 .”
Self-citationUnveiling DNA methylation in Alzheimer’s disease: a review of array-based human brain studies
Alves, V. C., Carro, E., & Figueiro‐Silva, J. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.393106 · Cited by 13
“Lunnon et al. (2014) focused on the APOE promoter region, unveiling a lack of statistically significant differences in DNAm.”
BackgroundThe broken Alzheimer’s disease genome
Roque, C. G., Phatnani, H. P., & Hengst, U. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100555 · Cited by 13
Blood DNA methylation signature for incident dementia: Evidence from longitudinal cohorts
Zhang, W., Young, J. I., Gomez, L., Schmidt, M. A., Lukacsovich, D., Kunkle, B. W., Chen, X. S., Martin, E. R., & Wang, L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14496 · Cited by 14
“The quality-controlled data was next normalized using the dasen method, as implemented in the wateRmelon R package 28 .”
Chi, S., Song, J., Tan, M., Zhang, W., Wang, Z.-X., Jiang, T., Tan, L., & Yu, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9547-x · Cited by 13
“Of interest, in De Jager’s study, the CpG hypermethylationassociated expression of ANK1 was connected to an already known AD gene, PTK2B, instead of APOE [11].”
BackgroundInfluentialZhao, K., Oualkacha, K., Lakhal‐Chaieb, L., Labbe, A., Klein, K., Ciampi, A., Hudson, M., Colmegna, I., Pastinen, T., Zhang, T., et al. (2020) · Biometrics · doi:10.1111/biom.13307 · Cited by 14
“Localized differential methylation is a characteristic feature of many diseases, such as diabetes (Nilsson et al. , 2014), Alzheimer’s disease (De Jager et al. , 2014) and autoimmune disorders (Liu et al. , 2013).”
Barrera, J., Song, L., Safi, A., Yun, Y., Garrett, M. E., Gamache, J., Premasinghe, I., Sprague, D., Chipman, D., Li, J., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00481-0 · Cited by 14
Chan, F.-Y., Kurosaki, R., Ganser, C., Takeda, T., & Uchihashi, T. (2022) · Review of Scientific Instruments · doi:10.1063/5.0111017 · Cited by 13
Pharmacological intervention of early neuropathy in neurodegenerative diseases
Kwon, M. J., Kim, J., Kim, T. S., & Lee, S. B. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.003 · Cited by 13
An emerging role for epigenetic factors in relation to executive function
Ibrahim, O., Sutherland, H., Haupt, L., & Griffiths, L. (2018) · Briefings in Functional Genomics · doi:10.1093/bfgp/elx032 · Cited by 8
Han, K., Han, M.-R., Kim, A., Kang, W., Kang, Y., Kang, J. C., Tae, W., Cho, Y., & Ham, B. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.10.039 · Cited by 13
Bhaduri, S., Scott, N. A., & Neal, S. E. (2022) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041248 · Cited by 13
A gene-level methylome-wide association analysis identifies novel Alzheimer’s disease genes
Wu, C., Bradley, J. R., Li, Y., Wu, L., & Deng, H. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab045 · Cited by 11
Sharma, A., Müller, J., Schuetze, K., Rolfes, V., Bissinger, R., Rosero, N., Ahmad, A., Franklin, B. S., Zur, B., Fröhlich, H., et al. (2021) · Biology · doi:10.3390/biology10080716 · Cited by 12
Liquid Biopsy in Alzheimer’s Disease Patients Reveals Epigenetic Changes in the PRLHR Gene
Macías, M., Acha, B., Corroza, J., Urdánoz‐Casado, A., Roldán, M., Robles, M., de Gordoa, J. S., Erro, M. E., Jericó, I., Blanco‐Luquin, I., et al. (2023) · Cells · doi:10.3390/cells12232679 · Cited by 11
“Moreover, epigenome-wide studies have Cells 2023 , 12 , 2679 2 of 15 also revealed differentially methylated genes previously related to AD across different vulnerable brain regions in postmortem samples, such as ANK1 [4,5], HOXA cluster [6], ABCA7 [7], TREM2 [8], or MAMSTR [9].”
Backgroundİş, Ö., Min, Y., Wang, X., Oatman, S. R., Daniel, A. A., & Ertekin‐Taner, N. (2024) · Glia · doi:10.1002/glia.24652 · Cited by 13
Self-citationEpigenetics of cell fate reprogramming and its implications for neurological disorders modelling
Grzybek, M., Golonko, A., Walczak, M., & Lisowski, P. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.11.007 · Cited by 12
Emerging roles of rhomboid‐like pseudoproteases in inflammatory and innate immune responses
Luo, W., & Shu, H. (2017) · FEBS Letters · doi:10.1002/1873-3468.12796 · Cited by 12
Transcriptome profiling of mouse brain and lung under Dip2a regulation using RNA-sequencing
Sah, R. K., Yang, A., Bah, F. B., Adlat, S., Bohio, A. A., Oo, Z. M., Wang, C., Myint, M. Z. Z., Bahadar, N., Zhang, L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213702 · Cited by 12
Using Proteomics to Understand Alzheimer’s Disease Pathogenesis
Drummond, E., & Wısnıewskı, T. (2019) · Codon Publications eBooks · doi:10.15586/alzheimersdisease.2019.ch3 · Cited by 13
Allegra, A., Giarratana, R. M., Scola, L., & Balistreri, C. R. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111461 · Cited by 12
ADmeth: A Manually Curated Database for the Differential Methylation in Alzheimer's Disease
Peng, X., Zhang, W., Cui, W., Ding, B., Lyu, Q., & Wang, J. (2022) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3178087 · Cited by 12
“ANK1 has been reported to be differentially methylated in the brain of AD cases in several studies [9], [20], [44].”
BackgroundSteyaert, S., Diddens, J., Galle, J., Meester, E. D., Keulenaer, S. D., Bakker, A., Sohnius‐Wilhelmi, N., Frankl‐Vilches, C., der Linden, A. V., Criekinge, W. V., et al. (2016) · Scientific Reports · doi:10.1038/srep20957 · Cited by 12
Differential blood DNA methylation across Lewy body dementias
Nasamran, C. A., Sachan, A. N. S., Mott, J., Kuras, Y. I., Scherzer, C. R., Study, H. B., Ricciardelli, E., Jepsen, K., Edland, S. D., Fisch, K. M., et al. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12156 · Cited by 12
Epigenetic Changes in Aging and Age-related Disease
Rowbotham, D. A. (2015) · Journal of Aging Science · doi:10.4172/2329-8847.1000130 · Cited by 13
“Early DNA methylation alterations at ankyrin 1 (ANK1), disco-interacting protein 2 (DIP2A), rhomboid family member 2 (RHBDF2), ribosomal protein L13 (RPL13), SERPINF1 and SERPINF2 are connected to a network of known AD susceptibility genes and may have a role in the onset of AD [116].”
BackgroundTargeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases
Fan, H., Chi, C.-S., Cheng, S.-N., Lee, H.-F., Tsai, J., Lin, S., & Harn, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010026 · Cited by 12
Exploring the Epigenetics of Alzheimer Disease
Traynor, B. J., & Renton, A. E. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3057 · Cited by 12
Rastad, S., Barjaste, N., Lanjanian, H., Moeini, A., Anka, F., & Masoudi‐Nejad, A. (2022) · Genes & Genetic Systems · doi:10.1266/ggs.22-00022 · Cited by 12
Li, J. Z., Ramalingam, N., & Li, S. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01827 · Cited by 11
“In recent years, extensive epigenome studies on histone modifications in AD have yielded insights into their impact on disease initiation and progression (De Jager et al., 2014; Blanco-Luquin et al., 2020; Nativio et al., 2020; Chen et al., 2021).”
BackgroundLeung, S. K., Bamford, R. A., Jeffries, A. R., Castanho, I., Chioza, B. A., Flaxman, C. S., Moore, K., Dempster, E. L., Harvey, J., Brown, J. T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50486-8 · Cited by 18
Self-citationWare, E. B., Tejera, C. H., Wang, H., Harris, S. M., Fisher, J., & Bakulski, K. M. (2024) · GeroScience · doi:10.1007/s11357-024-01356-0 · Cited by 12
Seddon, A. R., MacArthur, C. P., Hampton, M. B., & Stevens, A. J. (2024) · Redox Report · doi:10.1080/13510002.2024.2428152 · Cited by 11
Cheng, R., Tang, M., Martinez, I. M., Ayodele, T., Baez, P., Reyes‐Dumeyer, D., Lantigua, R., Medrano, M. Z., Jiménez‐Velázquez, I. Z., Lee, J. H., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.07.007 · Cited by 11
“CDH23, another member of the cadherin superfamily, has been previously associated with AD in an epigenetic association study [67].”
BackgroundInactive rhomboid proteins RHBDF1 and RHBDF2 (iRhoms): a decade of research in murine models
Burzenski, L. M., Low, B. E., Kohar, V., Shultz, L. D., Wiles, M. V., & Hosur, V. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09910-3 · Cited by 12
Multi-omics analysis revealed the role of CCT2 in the induction of autophagy in Alzheimer’s disease
Ma, X., Feng, Y., Quan, X., Geng, B., Li, G., Fu, X., & Zeng, L. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.967730 · Cited by 11
Mabondzo, A. M., Harati, R., Broca-Brisson, L., Guyot, A.-C., Costa, N., Cacciante, F., Putignano, E., Baroncelli, L., Skelton, M. R., Saab, C., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1118707 · Cited by 12
Mitochondrial Signaling and Neurodegeneration
Picard, M. A., & McManus, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-28637-2_5 · Cited by 11
Data-driven selection and parameter estimation for DNA methylation mathematical models
Larson, K. A., Zagkos, L., Auley, M. T. M., Roberts, J. A., Kavallaris, N. I., & Anastasios Matzavinos, A. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.01.012 · Cited by 11
A region-based method for causal mediation analysis of DNA methylation data
Yan, Q., Forno, E., Celedon, J. C., & Chen, W. (2021) · Epigenetics · doi:10.1080/15592294.2021.1900026 · Cited by 11
“In Settings (3) and (7), both approaches had similar power (Figures 4, 5, S14 and S17).”
Systems genetics identifies modifiers of Alzheimer’s disease risk and resiliencePreprint
Neuner, S. M., Hohman, T. J., Richholt, R., Bennett, D. A., Schneider, J. A., Jager, P. L. D., Huentelman, M. J., O’Connell, K. M. S., & Kaczorowski, C. C. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/225714 · Cited by 11
Self-citationPark, Y., He, L., Dávila-Velderrain, J., Hou, L., Mohammadi, S., Mathys, H., Peng, Z., Bennett, D. A., Tsai, L., & Kellis, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.21.426000 · Cited by 11
Self-citationAllostatic interoception and brain health: From neurodegeneration to social adversities
Migeot, J., & Ibáñez, A. (2025) · Encyclopedia of the Human Brain · doi:10.1016/b978-0-12-820480-1.00025-5 · Cited by 10
Hackenhaar, F. S., Study, T. A. I. B. A. L., Josefsson, M., Adolfsson, A. N., Landfors, M., Kauppi, K., Porter, T., Milicic, L., Laws, S. M., Hultdin, M., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230039 · Cited by 10
Evaluating genomic signatures of aging in brain tissue as it relates to Alzheimer’s disease
Lynch, M. T., Taub, M. A., Farfel, J. M., Yang, J., Abadir, P., De Jager, P. L., Grodstein, F., Bennett, D. A., & Mathias, R. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-41400-1 · Cited by 10
Self-citationThe Role of RIN3 Gene in Alzheimer’s Disease Pathogenesis: a Comprehensive Review
Meshref, M. M., Ghaith, H. S., Hammad, M. A., Shalaby, M. M. M., Ayasra, F., Monib, F. A., Attia, M. S., Ebada, M. A., Elsayed, H., Shalash, A., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03802-0 · Cited by 12
Peng, Q., Gilder, D. A., Bernert, R. A., Karriker‐Jaffe, K. J., & Ehlers, C. L. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02379-3 · Cited by 11
Shen, Y., Zhu, W., Li, S. C., Zhang, Z., Zhang, J., Li, M., Zheng, W., Wang, D., Zhong, Y., Li, M., et al. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.08.021 · Cited by 10
Shwab, E. K., Pathak, G. A., Harvey, J., Belloy, M. E., Fischer, C. E., Lutz, M. W., Scholz, S. W., Cook, N., Reid, D. M., Chen, J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70549 · Cited by 12
A scalable approach to investigating sequence-to-function predictions from personal genomes
Spiro, A. E., Tu, X., Sheng, Y., Sasse, A., Hosseini, R., Chikina, M. D., & Mostafavi, S. (2026) · Nature Methods · doi:10.1038/s41592-026-03124-8 · Cited by 15
“We set l1_ratio (which determines the balance between L1 and L2 penalties within the elastic net penalty) to 0.5 and use ROSMAP validation individuals (n=85) to select alpha (the weight on the elastic net penalty) for each gene using ElasticNetCV.”
InfluentialDunnet, M. J., Ortega‐Recalde, O., Waters, S. A., Weeks, R. J., Morison, I. M., & Hore, T. A. (2022) · Epigenetics Communications · doi:10.1186/s43682-022-00011-z · Cited by 11
“Others mentioned leukocyte infiltration as a possibility or discussed cellular heterogeneity [22, 23, 28, 32, 34] but did not control for this variability.”
BackgroundLiao, J., Mi, X., Zeng, G., Wei, Y., Dai, X., Ye, Q., Chen, X., & Zhang, J. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.086 · Cited by 9
Pramio, D. T., Vieceli, F. M., Branco, E. V., Goes, C. P., Kobayashi, G. S., Pellegrina, D. V. D. S., de Moraes, B. C., Allam, A. E., Kumar, B. D., Jara, G. E., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2023.194909 · Cited by 10
Self-citationWu, S., Yang, F., Shan, C., Wang, B., Wang, W., Li, H., Yu, L., He, L., Li, X., Sun, L., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1175864 · Cited by 10
“…methylated loci, such as ANK1, BIN1, RPL13, CDH23 and RHBDF2, associated with cognitive decline and AD dementia progression (Bakulski et al., 2012; De Jager et al., 2014; Lord and Cruchaga, 2014; Frontiers in Genetics frontiersin.org02 Lunnon et al., 2014; Watson et al., 2016; Ellison et al.,…”
BackgroundSelf-citationMakhlouf, M., de Souza, D. G., Kurian, S. M., Bellaver, B., Ellis, H., Kuboki, A., Al-Naama, A., Hasnah, R., Venturin, G. T., da Costa, J. C., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101837 · Cited by 11
“Next, we focused on the canonical markers of the major cell types populating the CNS: neurons (NEUs), astrocytes (ASTs), microglia (MCGs), oligodendrocytes (OGDs), oligodendrocyte progenitors (OPCs), and endothelial cells (ENDs) [63 e 65].”
Liu, E., Zhou, Q., Xie, A., Li, M., Zhang, S., Huang, H., Liuyang, Z., Wang, Y., Liu, B., Li, X., et al. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0149-9 · Cited by 10
“Since the posttranslational modification of histones has a strong association with the burden of AD pathology [18, 19], we hypothesize that GEE may improve the offspring’s pathology and cognitive functions by modulating histone acetylation.”
Epigenetic predictors of lifestyle traits applied to the blood and brain
Gadd, D. A., Stevenson, A. J., Hillary, R. F., McCartney, D. L., Wrobel, N., McCafferty, S., Murphy, L., Russ, T. C., Harris, S. E., Redmond, P. H., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab082 · Cited by 10
Wang, M., Gong, C., Amakye, W. K., & Ren, J. (2021) · eFood · doi:10.53365/efood.k/144885 · Cited by 10
“In recent years, emerging evidence shows that epigenetic biology such as histone modification, DNA methylation, chromatin remodeling, plays a role in AD [28, 29].”
Gene expression and epigenetic markers of prion diseases
Viré, E. A., & Mead, S. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03603-2 · Cited by 10
Keifer, J. (2017) · Genes · doi:10.3390/genes8020069 · Cited by 10
Mullins, R. J., & Kapogiannis, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.908650 · Cited by 9
Lin, J.-H., Yang, S., Wang, C., Yu, E., Zhu, Z., Shi, J., Li, X., Xin, J., Chen, X., & Pan, X. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220701 · Cited by 9
Differential Gene Expression and DNA Methylation in the Risk of Depression in LOAD Patients
Upadhya, S., Gingerich, D. O., Lutz, M. W., & Chiba‐Falek, O. (2022) · Biomolecules · doi:10.3390/biom12111679 · Cited by 9
Lukacsovich, D., O’Shea, D. M., Huang, H., Zhang, W., Young, J. I., Chen, X. S., Dietrich, S., Kunkle, B. W., Martin, E. R., & Wang, L. (2024) · Database · doi:10.1093/database/baae061 · Cited by 9
“Notably, two independent epigenome-wide association studies (EWAS) (19, 31) identified and replicated a number of loci robustly associated with AD neuropathology in the brain.”
Cheishvili, D., Carmo, S. D., Caraci, F., Grasso, M., Cuello, A. C., & Moshe Szyf, A. (2025) · Aging · doi:10.18632/aging.206188 · Cited by 10
Histone modifications: Key players in Alzheimer's disease
Li, K., Qiu, X., Yang, Q., & Wang, Z. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112102 · Cited by 12
Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics
Fathi, E., Farahzadi, R., Montazersaheb, S., & Bagheri, Y. (2020) · Current Gene Therapy · doi:10.2174/1566523220999201111194554 · Cited by 9
Albala, B., Appelmans, E., Burress, R., Santi, S. D., Devins, T., Klein, G., Logovinsky, V., Novak, G., Ribeiro, K., Schmidt, M. E., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13483 · Cited by 8
Kanarik, M., Liiver, K., Školnaja, M., Teino, I., Org, T., Laugus, K., Shimmo, R., Karelson, M. M., Saarma, M., & Harro, J. (2024) · Acta Neuropsychiatrica · doi:10.1017/neu.2024.36 · Cited by 8
“Serpinf2 that encodes a serine protease inhibitor has a link to Alzheimer ’ s disease (De Jager et al ., 2014), but was recently found as differentially expressed in a rat model of depression (Liao et al ., 2023).”
Background
Metadata
- Authors
- De Jager, P. L., Srivastava, G., Lunnon, K., Burgess, J., Schalkwyk, L. C., Yu, L., Eaton, M. L., Keenan, B. T., Ernst, J., McCabe, C., Tang, A., Raj, T., Replogle, J., Brodeur, W., Gabriel, S., Chai, H. S., Younkin, C., Younkin, S. G., Zou, F., Szyf, M., Epstein, C. B., Schneider, J. A., Bernstein, B. E., Meissner, A., Ertekin-Taner, N., Chibnik, L. B., Kellis, M., Mill, J., & Bennett, D. A.
- Affiliations
- Broad Institute (US)
- King's College London (GB)
- Mayo Clinic (US)
- Rush University Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Bennett, David A
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2014-08-17
- Volume
- 17
- Issue
- 9
- Pages
- 1156-1163
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC4292795
- OpenAlex
- W2074750860
- Cited by
- 956
- References
- 62
- Citations by year
- 2026: 49 · 2025: 77 · 2024: 74 · 2023: 69 · 2022: 82 · 2021: 94 · 2020: 93 · 2019: 94 · 2018: 93 · 2017: 71 · 2016: 84 · 2015: 59 · 2014: 17
- FWCI
- 31.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Open Access at Essex (University of Essex) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Open Research Exeter (University of Exeter) (submittedVersion)
- Funders
- National Institute on Aging (R01AG017917, P30-AG 10161, K25AG041906, R01AG036039, R01‐AG17917, R01 AG15819, R01AG018023, R01AG036836, U01AG046152, R01-AG18023, AG036039, R01AG036042, R01AG015819, P30AG010161, RC2AG036547, R01AG032990, U01AG046139, RF1AG015819, RF1AG036042, P50AG016574)
- National Human Genome Research Institute (R01HG004037)
- National Institute of Neurological Disorders and Stroke (R01NS080820)
- National Institute of Environmental Health Sciences (U01ES017155)
- National Center for Research Resources (KL2RR024151)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, DNA methylation, ANK1, BIN1, RHBDF2, ABCA7, differentially methylated regions, gene expression, preclinical Alzheimer's disease, epigenome-wide association study
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Amyloidosis, Brain, Carrier Proteins, Female, Humans, Male, Middle Aged, Nuclear Proteins, Ankyrins, CpG Islands, DNA Methylation, Genetic Predisposition to Disease, Tumor Suppressor Proteins, Intracellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Genome-Wide Association Study, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
